Health
T cells target broad range of SARS-CoV-2 epitopes, study shows – Drug Target Review
A study has found that T cells combat SARS-CoV-2 by targeting many sites on the coronavirus, not just the Spike protein.
Posted: 29 January 2021 | Victoria Rees (Drug Target Review) | No comments yet
A study has found that T cells combat SARS-CoV-2 by targeting many sites on the coronavirus, not just the Spike protein.
A new study has suggested that T cells combat SARS-CoV-2 by targeting a broad range of sites on the virus, beyond the key sites on the virus’s Spike (S) protein. By attacking the coronavirus from many angles, the body can potentially recognise different SARS-CoV-2 variants. The study was led by scientists…
-
General19 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire
-
General21 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News21 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland